Armata Pharmaceuticals Inc (ARMP)
2.75
-0.17
(-5.82%)
USD |
NYAM |
May 15, 14:46
Armata Pharmaceuticals Cash from Investing (Quarterly): -0.25M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.25M |
| December 31, 2023 | -2.39M |
| September 30, 2023 | -3.512M |
| June 30, 2023 | -0.222M |
| March 31, 2023 | -2.01M |
| December 31, 2022 | 0.455M |
| September 30, 2022 | -1.294M |
| June 30, 2022 | -1.136M |
| March 31, 2022 | -0.236M |
| December 31, 2021 | -0.228M |
| September 30, 2021 | -0.582M |
| June 30, 2021 | -0.196M |
| March 31, 2021 | -0.298M |
| December 31, 2020 | -0.366M |
| September 30, 2020 | -0.081M |
| June 30, 2020 | -0.273M |
| March 31, 2020 | -0.104M |
| December 31, 2019 | 0.072M |
| September 30, 2019 | 0.065M |
| June 30, 2019 | 2.882M |
| March 31, 2019 | -0.142M |
| December 31, 2018 | -9.393M |
| September 30, 2018 | 9.38M |
| June 30, 2018 | -0.031M |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | -0.018M |
| September 30, 2017 | -0.033M |
| June 30, 2017 | -0.002M |
| March 31, 2017 | -0.005M |
| December 31, 2016 | -0.013M |
| September 30, 2016 | -0.029M |
| June 30, 2016 | -0.125M |
| March 31, 2016 | -0.112M |
| December 31, 2015 | -0.05M |
| September 30, 2015 | -0.116M |
| June 30, 2015 | -0.009M |
| March 31, 2015 | -0.035M |
| December 31, 2014 | -0.005M |
| September 30, 2014 | -0.137M |
| June 30, 2014 | -0.831M |
| March 31, 2014 | -0.229M |
| December 31, 2013 | -0.005M |
| September 30, 2013 | -0.032M |
| June 30, 2013 | -0.065M |
| March 31, 2013 | 0.00 |
| September 30, 2009 | 0.258M |
| June 30, 2009 | -0.005M |
| March 31, 2009 | -0.006M |
| December 31, 2008 | -0.099M |
| September 30, 2008 | -0.033M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.512M
Minimum
Sep 2023
2.882M
Maximum
Jun 2019
-0.4852M
Average
-0.243M
Median
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -0.214M |
| Perspective Therapeutics Inc | -0.089M |
| Protalix BioTherapeutics Inc | -0.606M |
| Electromed Inc | -0.129M |
| Xtant Medical Holdings Inc | -2.313M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.58M |
| Cash from Financing (Quarterly) | 34.93M |
| Free Cash Flow | -46.82M |
| Free Cash Flow Per Share (Quarterly) | -0.2999 |
| Free Cash Flow Yield | -41.31% |